ArticleCancers2024

Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.

Palma Fedele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.